Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Genet Mol Res ; 12(2): 1731-9, 2013 May 21.
Article in English | MEDLINE | ID: mdl-23765979

ABSTRACT

DNA was recovered from teeth of 2 great ape skeletons, Pan troglodytes (Ptr) and Pongo pygmaeus (Ppy), belonging to a 19th-century zoological collection. The skeletons presented morphological alterations possibly associated with ß-thalassemia: Ptr had deformation of the calvaria and oro-maxillo-facial bones with porotic hyperostosis and extended osteoporotic lesions of the skeleton, while Ppy showed a general marked widening of the calvarial diploe but moderate osteoporotic signs on the post-cranial skeleton. We screened Ptr and Ppy for mutations in the ß-globin gene (exons 1, 2, and 3) because we suspected thalassemia. Ptr ß-globin sequences showed the highest degree of similarity with the human ones (99.8%), while those of Ppy were slightly different (98.2%). The results were consistent with the phylogenetic relationships between their β-globin gene sequences. We did not find any mutation in the ß-globin gene of Ptr and Ppy; therefore, we conclude that, in spite of skeletal alterations, the 2 subjects analyzed were not affected by ß-thalassemia.


Subject(s)
DNA/genetics , Pan troglodytes/genetics , Pongo pygmaeus/genetics , beta-Globins/genetics , beta-Thalassemia/genetics , Amino Acid Sequence , Animals , Base Sequence , Bone and Bones/pathology , Electrophoresis, Agar Gel , Exons/genetics , Humans , Likelihood Functions , Molecular Sequence Data , Phylogeny , Sequence Alignment , Skull/pathology , beta-Globins/chemistry
2.
Med Hypotheses ; 80(1): 67-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23168296

ABSTRACT

Mevalonate Kinase Deficiency (MKD) is an autosomal-recessively inherited disorder of cholesterol biosynthesis with higher prevalence in the Netherlands and other North European countries. MKD is due to mutations in the second enzyme of mevalonate pathway (mevalonate kinase, MK/MVK) which results in reduced enzymatic activity and in the consequent shortage of downstream compounds. In most severe cases the deregulation of mevalonate pathway is associated with a decrease in serum cholesterol. More than 100 pathological mutations have been described in the MVK gene so far, and a founder effect has been hypothesized as responsible for the diffusion of the most frequent disease-associated mutations. In the acute phase of disease, patients affected with MKD present low cholesterol levels comparable to their basal physiologic conditions, already characterized by lower cholesterol levels when compared to healthy individuals. Low cholesterol levels are widely known to correlate with the reduction of cardiovascular events. We hypothesize a selective advantage for heterozygote carriers of the most frequent MVK mutations in those countries where the diet is characterized by high consumption of saturated animal fats rich in cholesterol. This could explain the maintenance in North European population of the main mutations leading to MKD and the distribution world-wide of these mutations that followed the migrations of North European populations.


Subject(s)
Biological Evolution , Genetic Predisposition to Disease/genetics , Mevalonate Kinase Deficiency/epidemiology , Mevalonate Kinase Deficiency/genetics , Phosphotransferases (Alcohol Group Acceptor)/genetics , Selection, Genetic , Cholesterol/blood , Diet, High-Fat , Europe/epidemiology , Genes, Recessive/genetics , Humans , Models, Biological , Mutation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...